BSE Live
Sep 29, 16:01Prev. Close
2463.75
Open Price
2450.60
Bid Price (Qty.)
2422.00 (5)
Offer Price (Qty.)
2500.00 (50)
NSE Live
Sep 29, 15:58Prev. Close
2465.20
Open Price
2450.00
Bid Price (Qty.)
2424.70 (332)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Ajanta Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 25.07 | 25.27 | 25.27 | 17.17 | 17.39 | |
Total Share Capital | 25.07 | 25.27 | 25.27 | 17.17 | 17.39 | |
Reserves and Surplus | 3,600.24 | 3,382.65 | 3,220.84 | 3,152.01 | 2,867.59 | |
Total Reserves and Surplus | 3,600.24 | 3,382.65 | 3,220.84 | 3,152.01 | 2,867.59 | |
Total Shareholders Funds | 3,625.31 | 3,413.57 | 3,246.45 | 3,169.18 | 2,884.98 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Liabilities [Net] | 110.51 | 108.50 | 97.72 | 101.87 | 92.17 | |
Other Long Term Liabilities | 27.44 | 26.13 | 28.63 | 20.42 | 20.89 | |
Long Term Provisions | 80.27 | 39.54 | 24.15 | 19.32 | 17.93 | |
Total Non-Current Liabilities | 218.22 | 174.17 | 150.50 | 141.61 | 130.99 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade Payables | 366.27 | 383.74 | 353.02 | 274.37 | 317.20 | |
Other Current Liabilities | 321.10 | 228.20 | 540.80 | 184.53 | 187.18 | |
Short Term Provisions | 23.35 | 17.76 | 14.02 | 10.80 | 11.71 | |
Total Current Liabilities | 710.72 | 629.70 | 907.84 | 469.70 | 516.09 | |
Total Capital And Liabilities | 4,554.25 | 4,217.44 | 4,304.79 | 3,780.49 | 3,532.06 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 1,696.65 | 1,452.28 | 1,479.13 | 1,478.09 | 1,502.37 | |
Intangible Assets | 45.31 | 12.61 | 4.88 | 5.82 | 7.52 | |
Capital Work-In-Progress | 176.27 | 256.45 | 209.47 | 152.86 | 108.19 | |
Other Assets | 0.00 | 0.00 | 0.00 | 8.41 | 8.90 | |
Fixed Assets | 1,918.23 | 1,721.34 | 1,693.48 | 1,645.18 | 1,626.98 | |
Non-Current Investments | 43.13 | 37.09 | 42.99 | 42.99 | 17.89 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 6.25 | |
Other Non-Current Assets | 16.83 | 17.34 | 17.13 | 35.31 | 44.73 | |
Total Non-Current Assets | 1,978.19 | 1,775.77 | 1,753.60 | 1,723.48 | 1,695.85 | |
CURRENT ASSETS | ||||||
Current Investments | 438.71 | 330.05 | 510.27 | 121.86 | 138.99 | |
Inventories | 739.29 | 677.79 | 683.77 | 635.11 | 634.22 | |
Trade Receivables | 1,225.81 | 1,207.67 | 977.63 | 1,043.62 | 782.30 | |
Cash And Cash Equivalents | 49.72 | 63.06 | 269.92 | 145.25 | 151.98 | |
Short Term Loans And Advances | 2.54 | 15.40 | 17.01 | 6.14 | 5.74 | |
OtherCurrentAssets | 119.99 | 147.70 | 92.59 | 105.03 | 122.98 | |
Total Current Assets | 2,576.06 | 2,441.67 | 2,551.19 | 2,057.01 | 1,836.21 | |
Total Assets | 4,554.25 | 4,217.44 | 4,304.79 | 3,780.49 | 3,532.06 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 144.28 | 161.39 | 91.52 | 76.44 | 168.98 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 487.20 | 398.83 | 429.31 | 366.23 | 231.45 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | 2,871.82 | 2,386.47 | 2,242.02 | 1,867.82 | 1,809.65 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 15.50 | 15.63 | 15.63 | 7.09 | 7.09 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | 43.13 | 37.09 | 42.99 | 42.99 | 17.89 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | 428.59 | 299.15 | 386.06 | 121.86 | 138.99 | |
Current Investments Unquoted Book Value | 10.12 | 30.90 | 124.21 | -- | -- |
22.09.2025
01.08.2025
29.07.2025
Ajanta Pharma Consolidated June 2025 Net Sales at Rs 1,302.65 crore, up 13.78% Y-o-Y
29.07.2025
Ajanta Pharma Standalone June 2025 Net Sales at Rs 1,208.56 crore, up 12.19% Y-o-Y
29.07.2025
Ajanta Pharma Consolidated June 2025 Net Sales at Rs 1,302.65 crore, up 13.78% Y-o-Y
29.07.2025
Ajanta Pharma Standalone June 2025 Net Sales at Rs 1,208.56 crore, up 12.19% Y-o-Y
02.05.2025
Ajanta Pharma Consolidated March 2025 Net Sales at Rs 1,170.41 crore, up 11.04% Y-o-Y
02.05.2025
Ajanta Pharma Standalone March 2025 Net Sales at Rs 1,013.94 crore, up 9.49% Y-o-Y
12.07.2023
Ajanta Pharma Q1 PAT seen up 9.1% YoY to Rs 190.5 cr: Nirmal Bang
13.07.2022
Ajanta Pharma Q1 PAT may dip 12.7% YoY to Rs 151.6 cr: ICICI Direct
11.01.2019
Ajanta Pharma Q3 PAT may dip 35.1% YoY to Rs. 95.8 cr: ICICI Direct
12.10.2018
Ajanta Pharma Q2 PAT may dip 16.5% YoY to Rs. 110.1 cr: ICICI Direct